These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

556 related articles for article (PubMed ID: 28424105)

  • 1. Specific impact of stimulant, alcohol and cannabis use disorders on first-episode psychosis: 2-year functional and symptomatic outcomes.
    Ouellet-Plamondon C; Abdel-Baki A; Salvat É; Potvin S
    Psychol Med; 2017 Oct; 47(14):2461-2471. PubMed ID: 28424105
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Symptomatic and functional outcomes of substance use disorder persistence 2 years after admission to a first-episode psychosis program.
    Abdel-Baki A; Ouellet-Plamondon C; Salvat É; Grar K; Potvin S
    Psychiatry Res; 2017 Jan; 247():113-119. PubMed ID: 27888680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cannabis use disorder and age at onset of psychosis--a study in first-episode patients.
    Schimmelmann BG; Conus P; Cotton SM; Kupferschmid S; Karow A; Schultze-Lutter F; McGorry PD; Lambert M
    Schizophr Res; 2011 Jun; 129(1):52-6. PubMed ID: 21498049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comorbid Cannabis and Tobacco Use Disorders in Hospitalized Patients with Psychotic-Spectrum Disorders.
    Reeves LE; Gaudiano BA; Metrik J; Guzman Holst C; Morena A; Sydnor VJ; Weinstock LM; Epstein-Lubow G
    J Dual Diagn; 2018; 14(3):171-180. PubMed ID: 30265850
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differences in associations between cannabis and stimulant disorders in first admission psychosis.
    Sara G; Burgess P; Malhi GS; Whiteford H; Hall W
    Schizophr Res; 2013 Jul; 147(2-3):216-22. PubMed ID: 23684162
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cannabis and stimulant disorders and readmission 2 years after first-episode psychosis.
    Sara GE; Burgess PM; Malhi GS; Whiteford HA; Hall WC
    Br J Psychiatry; 2014 Jun; 204(6):448-53. PubMed ID: 24578446
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of cannabis use on age of onset and clinical characteristics in first-episode psychotic patients. Data from the Psychosis Incident Cohort Outcome Study (PICOS).
    Tosato S; Lasalvia A; Bonetto C; Mazzoncini R; Cristofalo D; De Santi K; Bertani M; Bissoli S; Lazzarotto L; Marrella G; Lamonaca D; Riolo R; Gardellin F; Urbani A; Tansella M; Ruggeri M;
    J Psychiatr Res; 2013 Apr; 47(4):438-44. PubMed ID: 23290558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Substance misuse and early psychosis.
    Tucker P
    Australas Psychiatry; 2009 Aug; 17(4):291-4. PubMed ID: 19301164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alcohol confounds relationship between cannabis misuse and psychosis conversion in a high-risk sample.
    Auther AM; Cadenhead KS; Carrión RE; Addington J; Bearden CE; Cannon TD; McGlashan TH; Perkins DO; Seidman L; Tsuang M; Walker EF; Woods SW; Cornblatt BA
    Acta Psychiatr Scand; 2015 Jul; 132(1):60-8. PubMed ID: 25572323
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential effects of sex on substance use between first episode psychosis patients and healthy people.
    Núñez C; Ochoa S; Huerta-Ramos E; Baños I; Barajas A; Dolz M; Sánchez B; Del Cacho N; ; Usall J
    Compr Psychiatry; 2016 Aug; 69():169-78. PubMed ID: 27423358
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Premorbid cannabis use is associated with more symptoms and poorer functioning in schizophrenia spectrum disorder.
    Ringen PA; Nesvåg R; Helle S; Lagerberg TV; Lange EH; Løberg EM; Agartz I; Andreassen OA; Melle I
    Psychol Med; 2016 Nov; 46(15):3127-3136. PubMed ID: 27534999
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stimulant and other substance use disorders in schizophrenia: prevalence, correlates and impacts in a population sample.
    Sara GE; Burgess PM; Malhi GS; Whiteford HA; Hall WC
    Aust N Z J Psychiatry; 2014 Nov; 48(11):1036-47. PubMed ID: 24819935
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cannabis abuse effects on prepulse inhibition in patients with first episode psychosis in schizophrenia.
    Morales-Muñoz I; Jurado-Barba R; Caballero M; Rodríguez-Jiménez R; Jiménez-Arriero MÁ; Fernández-Guinea S; Rubio G
    J Neuropsychiatry Clin Neurosci; 2015; 27(1):48-53. PubMed ID: 25716487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Age-varying effects of cannabis use frequency and disorder on symptoms of psychosis, depression and anxiety in adolescents and adults.
    Leadbeater BJ; Ames ME; Linden-Carmichael AN
    Addiction; 2019 Feb; 114(2):278-293. PubMed ID: 30276906
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cannabis and Alcohol Abuse Among First Psychotic Episode Inpatients.
    Katz G; Kunyvsky Y; Hornik-Lurie T; Raskin S; Abramowitz MZ
    Isr J Psychiatry Relat Sci; 2016; 53(3):10-15. PubMed ID: 28492376
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cannabis Use Is Associated With Increased Psychotic Symptoms and Poorer Psychosocial Functioning in First-Episode Psychosis: A Report From the UK National EDEN Study.
    Seddon JL; Birchwood M; Copello A; Everard L; Jones PB; Fowler D; Amos T; Freemantle N; Sharma V; Marshall M; Singh SP
    Schizophr Bull; 2016 May; 42(3):619-25. PubMed ID: 26536902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypertensive Crisis-Related Hospitalizations and Subsequent Major Adverse Cardiac Events in Young Adults with Cannabis Use Disorder: A Nationwide Analysis.
    Desai R; Jain A; Sultan W; Gandhi Z; Raju AR; Varughese VJ; Jnaneswaran G; Agarwal C; Rizvi B; Mansuri Z; Gupta P; Kumar G; Sachdeva R
    Medicina (Kaunas); 2022 Oct; 58(10):. PubMed ID: 36295625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DSM-5 cannabis use disorder, substance use and DSM-5 specific substance-use disorders: Evaluating comorbidity in a population-based sample.
    Hayley AC; Stough C; Downey LA
    Eur Neuropsychopharmacol; 2017 Aug; 27(8):732-743. PubMed ID: 28663122
    [TBL] [Abstract][Full Text] [Related]  

  • 19. First episode schizophrenia-related psychosis and substance use disorders: acute response to olanzapine and haloperidol.
    Green AI; Tohen MF; Hamer RM; Strakowski SM; Lieberman JA; Glick I; Clark WS;
    Schizophr Res; 2004 Feb; 66(2-3):125-35. PubMed ID: 15061244
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prospective study of cannabis use in adolescents at clinical high risk for psychosis: impact on conversion to psychosis and functional outcome.
    Auther AM; McLaughlin D; Carrión RE; Nagachandran P; Correll CU; Cornblatt BA
    Psychol Med; 2012 Dec; 42(12):2485-97. PubMed ID: 22716931
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.